Many fast food chains are benefiting as McDonald's copes with its turnaround strategy, says a restaurant analyst.» Read More
CNBC's Bob Pisani tracks the day's biggest leaders and laggards.
If the Fed loses its "patience," that could mean a June rate hike, says Ron Insana — using Janet Yellen's logic.
Correction in oil prices making MLPs attractive again.
Patience and the Federal Reserve should the word patience come out of the statement
There's a group of stocks in the S&P 500 that's trading in the feared "death cross," a phenomenon chart analysts use to determine bearish trends.
For his latest "New Ideas" column, CNBC's Brian Sullivan discusses the big worry in the market today: the unrelenting rise in the U.S. dollar.
California drought proves we should conserve the ecology, but for the good of humankind.
100 carat diamonds are smashing world records.
Randall Bacon gets paid to be the stunt double for Seahawks Quarterback Russell Wilson in commercials
Time for sport brackets? “Mad Money” host Jim Cramer’s got the list of Wall Street ballers that will make you more money.
All of the sudden, stocks don't seem to care about the Fed potentially becoming less "patient."
U.S. stock index futures indicated a lower open on Tuesday, as investors awaited news from the U.S. Federal Reserve's two-day meeting.
More than two-thirds of respondents to the CNBC Fed Survey see the first interest rate hike coming in August, a month ahead of the prior survey.
Stocks are moving higher ahead of this week's Fed meeting. How to play the rally, with Alan Gayle, Ridgeworth Investments, and Robert Pavlik, Boston Private Wealth.
Colin Moore, Columbia Management Global CIO, discusses global markets, rising rates and U.S. financial conditions.
The head of Madison Square Garden Tad Smith is taking over at Sotheby's. CNBC's Robert Frank reports some top art dealers are surprised.
A handful of stocks have benefited after the Cardiology and CME Conferences. CNBC's Meg Tirrell names which ones to keep an eye on including AstraZeneca and Edwards Lifesciences.
The largest Russia exposed ETF has been down more than four percent since rumors on Vladimir Putin began. Jeff Saut, Raymond James, weighs in on rumors.
Latest new player in the handbag wars is Danielle Nicole.
David Seaburg, Cowen & Company, and Stacey Gilbert, Susquehanna Capital Group, discuss whether any of the larger oil companies will cut their dividends.